RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+40.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.16B
AUM Growth
+$3.16B
Cap. Flow
+$71.7M
Cap. Flow %
2.27%
Top 10 Hldgs %
29.57%
Holding
150
New
12
Increased
35
Reduced
32
Closed
19

Top Buys

1
JNJ icon
Johnson & Johnson
JNJ
$73.2M
2
HUM icon
Humana
HUM
$67.8M
3
APRE icon
Aprea Therapeutics
APRE
$33.2M
4
AXNX
Axonics, Inc. Common Stock
AXNX
$24.9M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$20.7M

Top Sells

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$49M
2
MDCO
Medicines Co
MDCO
$41.8M
3
ABBV icon
AbbVie
ABBV
$39.8M
4
SYK icon
Stryker
SYK
$38.7M
5
CI icon
Cigna
CI
$29M

Sector Composition

1 Healthcare 90.33%
2 Consumer Staples 0.66%
3 Consumer Discretionary 0.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SYRE icon
101
Spyre Therapeutics
SYRE
$996M
$6.11M 0.19%
800,000
– –
CHMA
102
DELISTED
Chiasma, Inc. Common Stock
CHMA
$5.75M 0.18%
1,160,000
+260,000
+29% +$1.29M
HCAT icon
103
Health Catalyst
HCAT
$239M
$5.55M 0.18%
160,000
+35,000
+28% +$1.21M
TXG icon
104
10x Genomics
TXG
$1.74B
$5.53M 0.17%
72,500
+9,000
+14% +$686K
SRGA
105
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.34M 0.17%
1,950,000
– –
SPRO icon
106
Spero Therapeutics
SPRO
$116M
$5.05M 0.16%
525,000
– –
AKRO icon
107
Akero Therapeutics
AKRO
$3.74B
$4.99M 0.16%
225,000
– –
CO
108
DELISTED
Global Cord Blood Corporation
CO
$4.63M 0.15%
925,000
– –
GMDA
109
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$4.3M 0.14%
1,000,000
– –
BLUE
110
DELISTED
bluebird bio
BLUE
$3.07M 0.1%
35,000
-12,000
-26% -$1.05M
ACRS icon
111
Aclaris Therapeutics
ACRS
$209M
$3.02M 0.1%
1,600,000
-1,374,754
-46% -$2.6M
OBSV
112
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.02M 0.1%
789,480
-570,520
-42% -$2.18M
NBRV
113
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.77M 0.09%
2,100,000
-200,000
-9% -$264K
MGNX icon
114
MacroGenics
MGNX
$110M
$2.5M 0.08%
230,000
-70,000
-23% -$761K
ANAB icon
115
AnaptysBio
ANAB
$569M
$2.19M 0.07%
135,000
-105,000
-44% -$1.71M
FPRX
116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.84M 0.06%
400,000
-375,000
-48% -$1.72M
PRTK
117
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.51M 0.05%
375,000
-75,000
-17% -$302K
ADAP
118
Adaptimmune Therapeutics
ADAP
$15.3M
$960K 0.03%
800,000
-75,000
-9% -$90K
CRVS icon
119
Corvus Pharmaceuticals
CRVS
$428M
$816K 0.03%
150,000
-250,000
-63% -$1.36M
BMY.RT
120
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$557K 0.02%
+185,150
New +$557K
APLT icon
121
Applied Therapeutics
APLT
$74.9M
$554K 0.02%
+20,315
New +$554K
PFE icon
122
Pfizer
PFE
$142B
$407K 0.01%
+10,400
New +$407K
CVET
123
DELISTED
Covetrus, Inc. Common Stock
CVET
$273K 0.01%
20,683
– –
ABBV icon
124
AbbVie
ABBV
$374B
– –
-525,000
Closed -$39.8M
ABT icon
125
Abbott
ABT
$231B
– –
-122,500
Closed -$10.3M
2 3 4
5
6